The pathogenesis of cardiovascular diseases is complex. Yet the number of investigators trained to deal with whole organism diseases is decreasing. Accordingly, we propose to train future vascular biologists capable of implementing integrated approaches combining """"""""cellular"""""""", """"""""whole animal"""""""" and """"""""human"""""""" systems through multidisciplinary collaborations that begins during pre-doctoral training. We have developed an interdisciplinary program for predoctoral training in Integrative Vascular Biology (IVB) at the University of North Carolina with the stated goal of stimulating students to collaborate, and to unite them as an IVB group. The success of the IVB Program to date, which began four years ago with the curren T32 funding, is clearly, demonstrated by the number of trainees who went on to obtain individual fellowships from AHA and other sources (7/16) and of travel/poster awards earned by the trainees at various meetings (total 17). The program has also stimmulated overall vascular biology research on UNC campus. This renewal application requests a funding to continue our IVB Program with a support for 15 pre-doctoral trainees per year. Trainees will be selected from graduate students already enrolled in departmental programs and curricula at UNC, and will be suported for up to three years. To encourage the multi-disciplinary approach, we require each trainee to have collaborating advisor(s) in addition to the conventional primary mentor. The IVB Program is administered by the campus-wide Program for Molecular Biology and Biotechnology. Dr. Nobuyo Maeda, Professor of Pathology and Laboratory Medicine, is the Director, and Dr. Mark Majesky, Professor of Genetics, is the Co-Director. The primary thesis advisors are faculty members (from 12 Departments in three Schools and one College at UNC), with a strong commitment to predoctoral training through vascular biology related research at the molecular, cellular, and whole organism levels. To form a body of complementing faculty with whom the trainees can choose to collaborate, the primary training faclty is joined by clinical faculty and scientists at UNC, who maintain active laboratories mainly with postdoctoral students, and by investigators at nearby Institutions in the Research Triangle area. With its outstanding history in vascular biology research, its strong group of investigators, and its strength in animal model studies, the IVB Program at UNC offers an outstanding environment for multidisciplinary training of pre-doctoral students.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-J (F1))
Program Officer
Roltsch, Mark
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Schools of Medicine
Chapel Hill
United States
Zip Code
Wu, Ming Jing; Wolska, Anna; Roberts, Benjamin S et al. (2018) Coexpression of novel furin-resistant LPL variants with lipase maturation factor 1 enhances LPL secretion and activity. J Lipid Res 59:2456-2465
Wylie, Lyndsay A; Mouillesseaux, Kevin P; Chong, Diana C et al. (2018) Developmental SMAD6 loss leads to blood vessel hemorrhage and disrupted endothelial cell junctions. Dev Biol 442:199-209
Wilczewski, Caralynn M; Hepperla, Austin J; Shimbo, Takashi et al. (2018) CHD4 and the NuRD complex directly control cardiac sarcomere formation. Proc Natl Acad Sci U S A 115:6727-6732
Porrello, Alessandro; Leslie, Patrick L; Harrison, Emily B et al. (2018) Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. Nat Commun 9:1988
Brown, Daniel; Samsa, Leigh Ann; Ito, Cade et al. (2018) Neuregulin-1 is essential for nerve plexus formation during cardiac maturation. J Cell Mol Med 22:2007-2017
Kattula, Sravya; Byrnes, James R; Martin, Sara M et al. (2018) Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice. Blood Adv 2:25-35
Davis, James P; Vadlamudi, Swarooparani; Roman, Tamara S et al. (2018) Enhancer deletion and allelic effects define a regulatory molecular mechanism at the VLDLR cholesterol GWAS locus. Hum Mol Genet :
Kuwahara, Yasumichi; Kennedy, Leslie M; Karnezis, Anthony N et al. (2018) High Frequency of Ovarian Cyst Development in Vhl2B/+;Snf5+/- Mice. Am J Pathol 188:1510-1516
Roman, Tamara S; Mohlke, Karen L (2018) Functional genomics and assays of regulatory activity detect mechanisms at loci for lipid traits and coronary artery disease. Curr Opin Genet Dev 50:52-59
Wang, Nan; Vendrov, Kimberly C; Simmons, Brian P et al. (2018) Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease. Prostaglandins Other Lipid Mediat 134:24-31

Showing the most recent 10 out of 174 publications